Journals / Abant Tıp Dergisi / 2026 / Cilt: 15 Sayı: 2

Predictors of Mortality in Neonates With Persistent Pulmonary Hypertension: A Retrospective Cohort Study

Naz Hizli(Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi)0000-0002-6008-8863
Helen Bornaun(University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital, Department of Pediatric Cardiology)0000-0001-9431-2256
Pages
185–195
Publication Date
2026-08-28
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our findings suggest that clinical indicators assessed particularly during the early postnatal period may be useful in predicting the risk of mortality in the neonatal intensive care unit.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Persistent pulmonary hypertension of the newborn (PPHN) is associated with substantial morbidity and mortality.
📊
Key Findings & Data:Materials and Methods: This retrospective cohort study included neonates admitted to the neonatal intensive care unit between January 1, 2019, and December 31, 2021, with a documented clinical and echocardiographic diagnosis of PPHN.
💡
Conclusion & Impact:Our findings suggest that clinical indicators assessed particularly during the early postnatal period may be useful in predicting the risk of mortality in the neonatal intensive care unit.
🔬Design:Araştırma Makalesi
📍Scope:2019 Verileri
⚙️Variables:Newborn · Pulmonary Hypertension · Mortality

Abstract

Objective: Persistent pulmonary hypertension of the newborn (PPHN) is associated with substantial morbidity and mortality. This study aimed to evaluate demographic, perinatal, umbilical cord blood gas, and echocardiographic parameters as potential predictors of in-hospital mortality in neonates with PPHN. Materials and Methods: This retrospective cohort study included neonates admitted to the neonatal intensive care unit between January 1, 2019, and December 31, 2021, with a documented clinical and echocardiographic diagnosis of PPHN. Patients were eligible if they were 0 to 28 days of age, had a gestational age greater than 24 weeks, and had available umbilical cord blood gas data. The primary outcome was in-hospital mortality. Univariable and multivariable logistic regression analyses were used to evaluate factors associated with mortality. Results: A total of 51 neonates were included in the final analysis. The median gestational age was 35 weeks, and the median birth weight was 2480 g. In-hospital mortality occurred in 16 patients (31.4%). Female sex was more frequent among non-survivors than survivors (75.0% vs. 34.3%, p=0.007). Survivors had higher gestational age than non-survivors [36 weeks (IQR, 33 to 38) vs. 31.5 weeks (IQR, 25.3 to 35.8), p=0.015]. Survivors also had higher 1-minute and 5-minute Apgar scores than non-survivors. Umbilical cord blood gas parameters and estimated pulmonary artery systolic pressure values did not differ significantly between groups. In multivariable logistic regression analysis, male sex (adjusted OR, 0.12; 95% CI, 0.02 to 0.60; p=0.010) and higher 1-minute Apgar score (adjusted OR, 0.67; 95% CI, 0.47 to 0.95; p=0.025) were independently associated with lower odds of in-hospital mortality. Conclusion: In this cohort of neonates with PPHN, in-hospital mortality was high. Male sex and higher 1-minute Apgar score were independently associated with lower mortality risk, whereas umbilical cord blood gas parameters and estimated pulmonary artery systolic pressure were not significant predictors. Our findings suggest that clinical indicators assessed particularly during the early postnatal period may be useful in predicting the risk of mortality in the neonatal intensive care unit.

🔖

Cite This Article

Hizli, N., Bornaun, H. (2026). Predictors of Mortality in Neonates With Persistent Pulmonary Hypertension: A Retrospective Cohort Study. Abant Tıp Dergisi, Cilt: 15 Sayı: 2, 185–195. https://doi.org/10.47493/abantmedj.1963582

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Singh Y, Lakshminrusimha S. Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn. Clin Perinatol. 2021;48(3):595-618.
  2. Jain A, McNamara PJ. Persistent pulmonary hypertension of the newborn: Advances in diagnosis and treatment. Semin Fetal Neonatal Med. 2015;20(4):262-71.
  3. Lakshminrusimha S, Keszler M. Persistent Pulmonary Hypertension of the Newborn. Neoreviews. 2015;16(12):e680-e92.
  4. Soni M, Joshi PK, Patel SC, Shreya D, Zamora DI, Patel GS, ve ark. Persistent Pulmonary Hypertension: A Look Into the Future Therapy. Cureus. 2021;13(12):e20377.
  5. Huang Y, Yang T, Liang X, Chen Y, Zhou P, Yu Z, ve ark. Global, regional and national trends in the burden of persistent pulmonary hypertension of the newborn and essentials of its management from 1993 to 2023: a scoping review. Front Pediatr. 2025;13:1502385.
  6. Konduri GG, Kim UO. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am. 2009;56(3):579-600.
  7. Teng RJ, Wu TJ. Persistent pulmonary hypertension of the newborn. J Formos Med Assoc. 2013;112(4):177-84.
  8. Mathew B, Lakshminrusimha S. Persistent Pulmonary Hypertension in the Newborn. Children (Basel). 2017;4(8):63.
  9. Martinho S, Adão R, Leite-Moreira AF, Brás-Silva C. Persistent Pulmonary Hypertension of the Newborn: Pathophysiological Mechanisms and Novel Therapeutic Approaches. Front Pediatr. 2020;8:342.
  10. Hernández-Díaz S, Van Marter LJ, Werler MM, Louik C, Mitchell AA. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics. 2007;120(2):e272-82.
  11. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7.
  12. Ivy D, Rosenzweig EB, Abman SH, Beghetti M, Bonnet D, Douwes JM, ve ark. Embracing the challenges of neonatal and paediatric pulmonary hypertension. Eur Respir J. 2024;64(4):2400473.
  13. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, ve ark. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-731.
  14. Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, ve ark. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037-99.
  15. de Boode WP, Singh Y, Molnar Z, Schubert U, Savoia M, Sehgal A, ve ark. Application of Neonatologist Performed Echocardiography in the assessment and management of persistent pulmonary hypertension of the newborn. Pediatr Res. 2018;84(Suppl 1):68-77.
  16. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70(4):657-62.
  17. Puthiyachirakkal M, Mhanna MJ. Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review. Front Pediatr. 2013;1:23.
  18. Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med. 2001;344(7):467-71.
  19. Mandell E, Kinsella JP, Abman SH. Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2021;56(3):661-9.